Please use this identifier to cite or link to this item:
|Title:||“Watching the Detectives” report of the general assembly of the EU project DETECTIVE Brussels, 24–25 November 2015|
|Authors:||FERNANDO Ruani N.; CHAUDHARI Umesh; ESCHER Sylvia E.; HENGSTLER Jan; HESCHELER Juergen; JENNINGS Paul; KEUN Hector C.; KLEINJANS Jos; KOLDE Raivo; KOLLIPARA Laxmikanth; KOPP-SCHNEIDER Annette; LIMONCIEL Alice; NEMADE Harshal; NGUEMO Filomain; PETERSON Hedi; PRIETO PERAITA Maria Del Pilar; RODRIGUES Robim; SACHINIDIS Agapios; SCHAEFER Christoph; SICKMANN Albert; SPITKOVSKY Dimitry; STOEBER Regina; VAN BREDA Simone; VAN DE WATER Bob; VIVIER Manon; ZAHEDI René P.; VINKEN Mathieu; ROGIERS Vera|
|Citation:||ARCHIVES OF TOXICOLOGY. SUPPLEMENT. ARCHIV FÜR TOXIKOLOGIE. SUPPLEMENT vol. 90 no. 6 p. 1529-1539|
|Type:||Articles in periodicals and books|
|Abstract:||SEURAT-1 is a joint research initiative between the European Commission and Cosmetics Europe aiming to develop in vitro- and in silico-based methods to replace the in vivo repeated dose systemic toxicity test used for the assessment of human safety. As one of the building blocks of SEURAT-1, the DETECTIVE project focused on a key element on which in vitro toxicity testing relies: the development of robust and reliable, sensitive and specific in vitro biomarkers and surrogate endpoints that can be used for safety assessments of chronically acting toxicants, relevant for humans. The work conducted by the DETECTIVE consortium partners has established a screening pipeline of functional and "-omics" technologies, including high-content and high-throughput screening platforms, to develop and investigate human biomarkers for repeated dose toxicity in cellular in vitro models. Identification and statistical selection of highly predictive biomarkers in a pathway- and evidence-based approach constitute a major step in an integrated approach towards the replacement of animal testing in human safety assessment. To discuss the final outcomes and achievements of the consortium, a meeting was organized in Brussels. This meeting brought together data-producing and supporting consortium partners. The presentations focused on the current state of ongoing and concluding projects and the strategies employed to identify new relevant biomarkers of toxicity. The outcomes and deliverables, including the dissemination of results in data-rich "-omics" databases, were discussed as were the future perspectives of the work completed under the DETECTIVE project. Although some projects were still in progress and required continued data analysis, this report summarizes the presentations, discussions and the outcomes of the project.|
|JRC Directorate:||Institute for Health and Consumer Protection Historical Collection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.